Bifidobacterium infantis
RxNorm 100213

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 100213 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Bifidobacterium infantis.

The following semantic concepts and normalized strings are associated with this clinical entity:

IN
Bifidobacterium infantis
AUI:12776525
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

INPrescribable

Ingredient (IN):
Bifidobacterium infantis
(Atom ID: 12776525)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
Bifidobacterium infantis
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
100213
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12776525
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
IN
Ingredient (A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).)
Source Code
100213
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.
UNII Crosswalk
EF3U3H7I76 - BIFIDOBACTERIUM LONGUM INFANTIS (INGREDIENT SUBSTANCE)
RxNorm to Unique Ingredient Identifier crosswalk.

Patient Education

Bifidobacteria


What is it? Bifidobacteria species are probiotics ("good" bacteria) that live in the intestines. They may help with diarrhea, constipation, and other intestinal disorders.

"Good" bacteria such as bifidobacteria can help break down food, absorb nutrients, and fight off "bad" organisms that might cause diseases.

Bifidobacteria are commonly used for diarrhea, constipation, and irritable bowel syndrome (IBS). They're also used for preventing the common cold or flu, and lots of other conditions, but there is no good scientific evidence to support many of these uses. There is also no good evidence to support using bifidobacteria for COVID-19.
[Learn More]


* Please review the disclaimer below.